CDC Releases Maternal Immunization Vital Signs Report

Oct 08, 2019 | Kimberly Sharpe-Scott

Today, CDC released its October 2019 Vital Signs Report, “Burden and Prevention of Influenza and Pertussis Among U.S. Pregnant Women and Infants.” This report includes the latest findings on influenza and Tdap (whooping cough) vaccination rates among pregnant women. Key points from the report include:

Currently, the rates for these vaccines are too low – only 1 in 3 pregnant women in the United States receives both flu and Tdap vaccines. We don’t want to miss any opportunity for pregnant women to protect themselves and their newborns from these devastating illnesses. Flu vaccination lowers risk of influenza hospitalization in pregnant women by an average of 40%. It also reduces the risk of her baby needing hospital care for influenza. When an expecting mother gets Tdap in the third trimester, it is 78% effective in preventing cases of whooping cough in babies less than 2 months old. Tdap vaccination during pregnancy is even more effective at preventing hospitalization due to whooping cough in newborns.

Data indicate that education, referring patients to a vaccine provider, and the offer of vaccination by a provider play a significant role with getting vaccinated. Among women whose healthcare providers offered vaccination or provided referrals, 65.7% received a flu vaccine and 70.5% received Tdap. By encouraging vaccinations during pregnancy, mothers can make an informed choice to protect themselves and give their babies early protection.

Below are other key points from the report:

  • Women with influenza are more than twice as likely to be hospitalized if they are pregnant, and babies less than 6 months old are at the highest risk of all children for influenza-associated hospitalization.
  • The majority (69%) of reported whooping cough deaths are in babies less than 2 months old.
  • Reported maternal flu and Tdap vaccination coverage rates were 54% and 55%, respectively.
  • Provider recommendations are vital—among women whose healthcare providers offered vaccination or provided referrals, 65.7% received a flu vaccine and 70.5% received Tdap—but many pregnant women do not receive the vaccines recommended to protect themselves and their newborns, even when offered vaccination. The most commonly reported reasons for non-vaccination were belief that the flu vaccine is not effective (17.6%) and not knowing that Tdap vaccination is needed during each pregnancy (37.9%).
  • Providers should start discussing the benefits of vaccination with women early in pregnancy, strongly recommend flu and Tdap vaccines to all pregnant women, and address women’s questions and concerns about getting vaccinated during pregnancy.

Visit the Vital Signs website to access the MMWR article, a two-page consumer fact sheet, social media content, graphics and other informative tools and resources.


About Kimberly Sharpe-Scott

More posts by Kimberly Sharpe-Scott

0 Comments

Related Posts

Cdc badge small
  • Tools & Resources

CDC Report: Temporary Reassignment of Personnel Requests...

CDC recently updated its flexibilities guidance for recipients and applicants...

Jul 09, 2020 | Kim Rodgers

CDC Report: Temporary Reassignment of Personnel Requests...

Jennifer kertanis headshot 24152456360
  • Opportunity

Top Moments From Day Two at NACCHO 360

Welcome to the final day of NACCHO 360! Yesterday NACCHO Chief Executive...

Jul 09, 2020 | Taylarr Lopez

Top Moments From Day Two at NACCHO 360

COVID VC Screenshot
  • COVID-19
  • Tools & Resources
  • Emergency Response
  • Infectious Disease

NACCHO’s COVID-19 Virtual Community Now Available to All...

NACCHO has opened our COVID-19 Virtual Community to all local health department...

Jul 08, 2020 | Kim Rodgers

NACCHO’s COVID-19 Virtual Community Now Available to All...

Sync2020 logos horizontal 1024x304
  • HIV, STI, & Viral Hepatitis

Scholarships Available: SYNChronicity 2020 Conference –...

SYNC 2020, the National Conference for HIV, HCV, STI and LGBTQ Health, is...

Jul 08, 2020 | Julia Zigman

Scholarships Available: SYNChronicity 2020 Conference –...

  • COVID-19
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

Kaiser Family Foundation: Reduction in Sexual and...

The Kaiser Family Foundation released a new issue brief, Potential Impacts of...

Jul 08, 2020 | Julia Zigman

Kaiser Family Foundation: Reduction in Sexual and...

2000px US CDC logo
  • HIV, STI, & Viral Hepatitis

New Recommendations for Hepatitis Vaccination

CDC has released new recommendations for hepatitis A virus (HAV) vaccination,...

Jul 08, 2020 | Julia Zigman

New Recommendations for Hepatitis Vaccination

TAG Logo
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

Treatment Action Group 2020 Pipeline Report Now Available

Treatment Action Group (TAG) recently published their 2020 Pipeline Report, an...

Jul 08, 2020 | Julia Zigman

Treatment Action Group 2020 Pipeline Report Now Available

Pr EP injectable
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

New Study: Injectable PrEP is Safe and Highly Effective

New data further shows an injectable antiretroviral for HIV pre-exposure...

Jul 08, 2020 | Julia Zigman

New Study: Injectable PrEP is Safe and Highly Effective

MMWR
  • HIV, STI, & Viral Hepatitis
  • Research & Reports

HIV Testing Trends at Visits to Physician Offices,...

A recent report from CDC shows low rates of HIV testing in physician offices,...

Jul 08, 2020 | Julia Zigman

HIV Testing Trends at Visits to Physician Offices,...

Back to Top